Literature DB >> 29166967

The clinical significance of drug-placebo differences.

I Kirsch1.   

Abstract

Keywords:  Adverse effects; antidepressants; depression; psychotropic drugs

Mesh：

Substances：

Year:  2017        PMID： 29166967      PMCID： PMC6998852          DOI： 10.1017/S2045796017000725

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN： 2045-7960            Impact factor:   6.892


× No keyword cloud information.
  7 in total

Review 1.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Nathaniel P Katz; Robert D Kerns; Gerold Stucki; Robert R Allen; Nicholas Bellamy; Daniel B Carr; Julie Chandler; Penney Cowan; Raymond Dionne; Bradley S Galer; Sharon Hertz; Alejandro R Jadad; Lynn D Kramer; Donald C Manning; Susan Martin; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; Wendye Robbins; James P Robinson; Margaret Rothman; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; Joachim Wernicke; James Witter
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

2.  Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences.

Authors:  Joanna Moncrieff; Irving Kirsch
Journal:  Contemp Clin Trials       Date:  2015-05-12       Impact factor: 2.226

3.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.

Authors:  John T Farrar; James P Young; Linda LaMoreaux; John L Werth; Michael R Poole
Journal:  Pain       Date:  2001-11       Impact factor: 6.961

Review 4.  Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.

Authors:  Stefan Leucht; Sandra Hierl; Werner Kissling; Markus Dold; John M Davis
Journal:  Br J Psychiatry       Date:  2012-02       Impact factor: 9.319

5.  What does the HAMD mean?

Authors:  Stefan Leucht; Hein Fennema; Rolf Engel; Marion Kaspers-Janssen; Peter Lepping; Armin Szegedi
Journal:  J Affect Disord       Date:  2013-01-26       Impact factor: 4.839

6.  How effective are common medications: a perspective based on meta-analyses of major drugs.

Authors:  Stefan Leucht; Bartosz Helfer; Gerald Gartlehner; John M Davis
Journal:  BMC Med       Date:  2015-10-02       Impact factor: 8.775

Review 7.  Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Janus Christian Jakobsen; Kiran Kumar Katakam; Anne Schou; Signe Gade Hellmuth; Sandra Elkjær Stallknecht; Katja Leth-Møller; Maria Iversen; Marianne Bjørnø Banke; Iggiannguaq Juhl Petersen; Sarah Louise Klingenberg; Jesper Krogh; Sebastian Elgaard Ebert; Anne Timm; Jane Lindschou; Christian Gluud
Journal:  BMC Psychiatry       Date:  2017-02-08       Impact factor: 3.630
  7 in total
  1 in total

1.  Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.

Authors:  Alan Prossin; Alisa Koch; Phillip Campbell; Geoffroy Laumet; Christian S Stohler; Robert Dantzer; Jon-Kar Zubieta
Journal:  Mol Psychiatry       Date:  2021-10-29       Impact factor: 13.437
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.